Veterinary Medicines

Syncroprost, 0.250 mg/ml solution for injection for cattle, horses, pigs and goats

Authorised
  • Cloprostenol
Download as PDF

Product identification

Medicine name:
Syncroprost 0,250 mg/ml solution injectable pour bouvins, chevaux, porcins et chevres
Syncroprost, 0.250 mg/ml solution for injection for cattle, horses, pigs and goats
Active substance:
  • Cloprostenol
Target species:
  • Cattle (cow)
  • Cattle (heifer)
  • Horse (mare)
  • Pig (female)
  • Goat (adult female)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Cloprostenol
    0.25
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle (cow)
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Cattle (heifer)
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Horse (mare)
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Pig (female)
      • Meat and offal
        1
        day
    • Goat (adult female)
      • Meat and offal
        1
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02AD90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Box with 10 x 20 ml vials. Type I colourless glass vials sealed with bromo-butyl rubber stoppers closed by aluminium flip-off caps.
  • Box with one 20 ml vial. Type I colourless glass vial sealed with bromo-butyl rubber stopper closed by aluminium flip-off cap.
  • Box with one 10 ml vial. Type I colourless glass vial sealed with bromo-butyl rubber stopper closed by aluminium flip-off cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetem S.p.A.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V 915/09/02/2023
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0147/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • Sweden

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 22/03/2023
Download

Combined File of all Documents

English (PDF)
Published on: 25/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."